Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $12.7 Million - $14.9 Million
-120,003 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $266,440 - $313,907
-2,448 Reduced 2.0%
120,003 $14.4 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $24,675 - $26,888
-235 Reduced 0.19%
122,451 $13.4 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $72,120 - $87,585
-787 Reduced 0.64%
122,686 $13.4 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $511,257 - $654,346
-6,677 Reduced 5.13%
123,473 $11.3 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $10,176 - $14,881
162 Added 0.12%
130,150 $10.3 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $37,213 - $41,427
-474 Reduced 0.36%
129,988 $11.3 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $211,556 - $229,392
-2,585 Reduced 1.94%
130,462 $10.9 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $115,004 - $134,130
-1,578 Reduced 1.17%
133,047 $11.2 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $299,645 - $362,271
-4,525 Reduced 3.25%
134,625 $10.8 Million
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $70,149 - $79,468
-1,070 Reduced 0.76%
139,150 $10.1 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $134,390 - $162,125
-2,210 Reduced 1.55%
140,220 $10.3 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $92.9 Million - $103 Million
-1,614,408 Reduced 91.89%
142,430 $8.69 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $236,840 - $267,776
-4,209 Reduced 0.24%
1,756,838 $105 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $30.4 Million - $32.5 Million
-565,848 Reduced 24.32%
1,761,047 $101 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $112 Million - $125 Million
2,326,895
2,326,895 $124 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.